ID: h-16591043d1
Hypothesis
Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition functions
The most actionable synthesis is that pathogenicity may depend more on conversion of C1q binding into classical-pathway protease activity than on C1q recognition alone.
EvidencePending (0%)📖 8 cit🗣 1 debates✓ 8 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
The most actionable synthesis is that pathogenicity may depend more on conversion of C1q binding into classical-pathway protease activity than on C1q recognition alone. In this model, inhibiting C1r/C1s should attenuate C4/C3-mediated synapse loss and neuroinflammation while preserving some homeostatic debris sensing and cargo recognition by C1q.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["C1Q Deficiency<br/>Impaired Clearance of Apoptotic Cells"]
B["C1QC Assembly<br/>Heterocomplex Formation"]
C["Synaptic Pruning Dysregulation<br/>Unpruned Connections"]
D["Microglial Overactivation<br/>Complement Deposition"]
E["C3b/C4b Deposition<br/>Neuronal Surface"]
F["Synaptic Loss<br/>Excessive Pruning in AD"]
G["Long-Term Potentiation<br/>Memory Formation Impaired"]
H["Cognitive Decline<br/>AD-Related Dementia"]
A --> B
B --> C
B --> D
C --> F
D --> E
E --> F
F --> G
G --> H
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix8 supports2 contradicts
Supports
C1q/C3-dependent synaptic pruning is established in development, supporting a pathogenic role for downstream complement activation at synapses.
Supports
Early AD-model synapse loss requires classical complement components and microglial CR3, supporting the idea that downstream cascade activation mediates injury.
Supports
Clinical and translational activity around C1q/classical pathway inhibition indicates tractable target biology and therapeutic interest.
Supports
Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease.
Supports
Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors.
Supports
Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.
Supports
A complement-microglial axis drives synapse loss during virus-induced memory impairment.
Supports
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta.
Contradicts
It remains unresolved whether C1q recognition is broadly beneficial in the CNS; some harmful effects may arise from C1q binding itself rather than only downstream protease activation.
Contradicts
Blocking C1r/C1s may still impair host defense and immune-complex handling, so CNS benefit may not cleanly separate from systemic risk.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — C1QA
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for C1QA,C1QB,C1QC,C1R,C1S,C4A,C4B,C3 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for C1QA,C1QB,C1QC,C1R,C1S,C4A,C4B,C3.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.5%
Volatility
Low
0.0074
Events (7d)
3
Price History
▼19.7%💾 Resource Usage
LLM Tokens
19,754
$0.0593
Total Cost
$0.0593
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF a selective C1r/C1s inhibitor (e.g., C1s-IN-1, 10 mg/kg daily) is administered to APP/PS1 transgenic mice starting at 3 months of age for 8 weeks, THEN the density of excitatory synapses in the hip | Hippocampal PSD95+ synapse density will increase by at least 20% relative to vehicle control. | — no observation — | pending | 0.65 |
| IF human iPSC-derived neurons co-cultured with microglia are treated with a selective C1r/C1s inhibitor (C1s-IN-1, 1 µM) for 48 h prior to exposure to oligomeric Aβ (1 µM), THEN the generation of C3a | Supernatant C3a concentration will be at least 30% lower in inhibitor-treated cultures, with no significant change in C1q synaptic coverage. | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF a selective C1r/C1s inhibitor (e.g., C1s-IN-1, 10 mg/kg daily) is administered to APP/PS1 transgenic mice starting at 3 months of age for 8 weeks, THEN the density of excitatory synapses in the hippocampus (measured by PSD95 immunostaining) will be significantly higher (≥20% increase) compared to
Predicted outcome: Hippocampal PSD95+ synapse density will increase by at least 20% relative to vehicle control.
Falsification: If PSD95+ synapse density in treated mice is not higher than vehicle (p>0.05) or is lower, the hypothesis is disproven.
pendingconf 55%
IF human iPSC-derived neurons co-cultured with microglia are treated with a selective C1r/C1s inhibitor (C1s-IN-1, 1 µM) for 48 h prior to exposure to oligomeric Aβ (1 µM), THEN the generation of C3a in the culture supernatant (measured by ELISA) will be reduced by at least 30% relative to vehicle,
Predicted outcome: Supernatant C3a concentration will be at least 30% lower in inhibitor-treated cultures, with no significant change in C1q synaptic coverage.
Falsification: If C3a levels are not reduced (p>0.05) or if C1q synaptic binding is significantly altered, the hypothesis is disproven.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.